Nursing Pharmacology Practice Test
November 10, 2012 by admin
Filed under cna nursing exam
Please select the appropriate response. Show concerns one by one
1, Increasing ion technology at pH ABOVE pKa:
* poor acid
* poor base
2, Faster medication absorption:
* lung
* stomach
3, General phrase having to do with activities of the body program on the drug:
* pharmacodynamics
* pharmacogenetics
* pharmacokinetics
* absorption
* none of the above
4, Example(s) of covalent drug-receptor interactions:
* triggered phenoxybenzamine-receptor
* anti-cancer DNA alkylating medication, like cyclophosphamide (Cytoxan)
* norepinephrine
* A & B
* A, B & C
5, Pharmacological antagonists:
* cause receptor down regulation
* avoid executed of other elements to the receptor by their executed to the receptor
* atropine (blocks ACh activity on the heart
* A & B
* B & C
6, Drug with this ion technology residence most likely to soften from bowel (pH 8.4) to blood vessels (pH 7.4)
* poor acidity (pKa 7.4)
* poor platform (pKa 8.4)
* poor acidity (pKa 8.4)
* poor platform (pKa 6.4)
* poor acidity (pKa 6.4)
7, Most essential aspect impacting medication intake amount following intramuscular injection:
* hook diameter
* amount of administration
* hypodermic injection website blood vessels flow
* hypodermic injection volume
8, Most typical procedure of medication permeation:
* endocytosis
* carrier-mediated transport
* active-transport
* inactive diffusion
* none of the above
9, Bond kind that is seen in some drug-receptor communications and tends to very powerful, often nearly irreversible:
* hydrophobic
* electrostatic
* covalent
* A & C
* B & C
10, Mechanism(s) of medication permeation:
* fat diffusion
* aqueous diffusion
* use of service provider molecules
* endocytosis and exocytosis
* all of the above
11, Weak natural acidity, pKa 6.5. % ion technology at pH 7.5
* 1%
* 10%
* 50%
* 90%
* 99%
12, Drug distribution technique LEAST appropriate for lengthy lasting (days to weeks) slowly launch.
* pellet improvement under the epidermis (subcutaneous)
* time launch capsule
* i.m. hypodermic injection of a drug-oil suspension
* transdermal patch
* none of the above
13, Most medication have molecular loads between:
* 10 – 100
* 100 and 1000
* 7 – about 60000
* above 60000
* none of the above
14, Drug-transport program described as “energy requiring”:
* glomerular filtration
* triggered diffusion
* effective transport
* B & C
* A, B & C
15, Term having to do with medication activities on the body:
* pharmacokinetics
* pharmacodynamics
* pharmacogenetics
* placebo
* all of the above
16, Dramatic loss of wide spread option a medication following dental management is most likely due to:
* excessive medication uncertainty at abdomen pH
* hepatic “first-pass” effect
* medication digested by gut flora
* product does not dissolve
* individual non-complance